Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial. // British Journal of Anaesthesia. – URL: https://www.sciencedirect.com/science/article/pii/S0007091226007889?dgcid=rss_sd_all
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial. British Journal of Anaesthesia. https://www.sciencedirect.com/science/article/pii/S0007091226007889?dgcid=rss_sd_all
“Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial.” British Journal of Anaesthesia.
@article{article38968,
title = {Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial},
journal = {British Journal of Anaesthesia},
url = {https://www.sciencedirect.com/science/article/pii/S0007091226007889?dgcid=rss_sd_all}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...